
Imuza Tablet
Marketer
Panacea Biotec Pharma Ltd
Salt Composition
Azathioprine (50mg)
Overview Imuza Tablet
Immunosuppressant medication, Imuza, is administered alongside other drugs post-transplant surgery (kidney, heart, liver, etc.) to mitigate organ rejection. It's also indicated in rheumatoid arthritis treatment. Imuza functions by reducing immune system activity, preventing organ attack. Dosage and frequency vary depending on the transplant type; adhere strictly to your physician's prescription. Take with food, consistently, even if feeling well; discontinuation increases rejection risk. Potential side effects are numerous; common ones include anorexia, nausea, and heightened bleeding susceptibility. Immunosuppression elevates infection and cancer risks. Report any concerning side effects promptly. Imuza is contraindicated during pregnancy, conception planning, or breastfeeding due to teratogenic and miscarriage risks. Consult your doctor before initiating Imuza if experiencing infection symptoms, unusual bleeding or bruising, or if using other medications, as drug interactions are possible. Regular blood tests will monitor blood cell counts.
Uses of Imuza Tablet
Immunosuppression for transplant recipients and management of rheumatoid arthritis.
Major Benefits of Imuza Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Imuza Tablet with a meal.
Common Side effects of Imuza Tablet:
- Decreased white blood cell count
- Increased bleeding tendency
- Nausea
- Infection
- Loss of appetite
How to use Imuza Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Imuza Tablet with food.
How Imuza Tablet works:
Imuza tablets function as an immunosuppressant medication, diminishing the activity of the body's natural immune response to prevent organ transplant rejection. This medication also inhibits specific inflammatory mediators, thereby mitigating the swelling, redness, and inflammation characteristic of some arthritic conditions.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Imuza Tablet may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Taking Imuza tablets during pregnancy poses a confirmed risk to the fetus, thus it's inadvisable. Nevertheless, in exceptional, life-threatening circumstances, a physician might exceptionally prescribe it when the potential advantages outweigh the inherent dangers. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Imuza Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Imuza Tablet on driving ability is unknown. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with impaired kidney function should use Imuza Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. Imuza Tablet is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Imuza Tablet, potentially requiring dosage modification. Consult your physician for guidance. Imuza Tablet is contraindicated in individuals with severe hepatic dysfunction. Routine liver function monitoring is recommended during treatment.
What if you forget to take Imuza Tablet :
Should you forget to take your Imuza Tablet, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Imuza Tablet
Label | Value |
---|---|
Chemical Type | Purine Nucleoside Analogs |
Developing Habits | No. |
Treatment Category | Cancer Drugs |
Action Class | Purine analog immunosuppressants |